BRPI0909634A2 - 2-aminoquinolinas - Google Patents
2-aminoquinolinasInfo
- Publication number
- BRPI0909634A2 BRPI0909634A2 BRPI0909634A BRPI0909634A BRPI0909634A2 BR PI0909634 A2 BRPI0909634 A2 BR PI0909634A2 BR PI0909634 A BRPI0909634 A BR PI0909634A BR PI0909634 A BRPI0909634 A BR PI0909634A BR PI0909634 A2 BRPI0909634 A2 BR PI0909634A2
- Authority
- BR
- Brazil
- Prior art keywords
- aminoquinolines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08152327 | 2008-03-05 | ||
| PCT/EP2009/052100 WO2009109477A1 (en) | 2008-03-05 | 2009-02-23 | 2-aminoquinolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0909634A2 true BRPI0909634A2 (pt) | 2015-09-22 |
Family
ID=40671014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0909634A BRPI0909634A2 (pt) | 2008-03-05 | 2009-02-23 | 2-aminoquinolinas |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8183380B2 (pt) |
| EP (1) | EP2262789A1 (pt) |
| JP (1) | JP2011513350A (pt) |
| KR (1) | KR20100119825A (pt) |
| CN (1) | CN101959876A (pt) |
| AU (1) | AU2009221375A1 (pt) |
| BR (1) | BRPI0909634A2 (pt) |
| CA (1) | CA2716122A1 (pt) |
| IL (1) | IL207698A0 (pt) |
| MX (1) | MX2010009574A (pt) |
| WO (1) | WO2009109477A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008303602A1 (en) * | 2007-09-27 | 2009-04-02 | F. Hoffmann-La Roche Ag | Quinoline derivatives as 5HT5A receptor antagonists |
| KR20100119789A (ko) * | 2008-03-07 | 2010-11-10 | 에프. 호프만-라 로슈 아게 | 2-아미노퀴놀린 |
| CA2919397C (en) | 2013-09-09 | 2021-05-18 | Peloton Therapeutics, Inc. | Aryl ethers as hif-2.alpha. inhibitors for the treatment of cancer |
| EP3267792A4 (en) | 2015-03-11 | 2018-09-26 | Peloton Therapeutics, Inc. | Compositions for use in treating pulmonary arterial hypertension |
| WO2016145045A1 (en) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Compositions for use in treating glioblastoma |
| US10807948B2 (en) * | 2015-03-11 | 2020-10-20 | Peloton Therapeutics, Inc. | Aromatic compounds and uses thereof |
| WO2016168510A1 (en) | 2015-04-17 | 2016-10-20 | Peloton Therapeutics, Inc. | Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof |
| CN108264535A (zh) | 2016-12-30 | 2018-07-10 | 中国科学院上海药物研究所 | 一种抗抑郁化合物及其制备方法和应用 |
| WO2024044792A1 (en) | 2022-08-26 | 2024-02-29 | Am Chemicals Llc | Universal solid supports and phosphoramidite building blocks for oligonucleotide synthesis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000042026A1 (en) * | 1999-01-15 | 2000-07-20 | Novo Nordisk A/S | Non-peptide glp-1 agonists |
| JP2005519876A (ja) * | 2001-11-27 | 2005-07-07 | メルク エンド カムパニー インコーポレーテッド | ２−アミノキノリン化合物 |
| CA2518398A1 (en) * | 2003-03-10 | 2004-09-23 | Schering Corporation | Heterocyclic kinase inhibitors: methods of use and synthesis |
| GB0309781D0 (en) | 2003-04-29 | 2003-06-04 | Glaxo Group Ltd | Compounds |
| DE102004008141A1 (de) | 2004-02-19 | 2005-09-01 | Abbott Gmbh & Co. Kg | Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren |
| ES2348208T3 (es) * | 2006-12-07 | 2010-12-01 | F. Hoffmann-La Roche Ag | 2-aminoquinolinas como antagonistas de receptores 5-ht (5a). |
| AU2008303602A1 (en) * | 2007-09-27 | 2009-04-02 | F. Hoffmann-La Roche Ag | Quinoline derivatives as 5HT5A receptor antagonists |
| EP2262773A1 (en) * | 2008-03-07 | 2010-12-22 | F. Hoffmann-La Roche AG | 2-aminoquinoline derivatives |
| KR20100119789A (ko) * | 2008-03-07 | 2010-11-10 | 에프. 호프만-라 로슈 아게 | 2-아미노퀴놀린 |
| CA2716907A1 (en) * | 2008-03-12 | 2009-09-17 | F. Hoffmann-La Roche Ag | 2-aminoquinolines as 5-ht5a receptor antagonists |
-
2009
- 2009-02-23 CA CA2716122A patent/CA2716122A1/en not_active Abandoned
- 2009-02-23 CN CN2009801062746A patent/CN101959876A/zh active Pending
- 2009-02-23 AU AU2009221375A patent/AU2009221375A1/en not_active Abandoned
- 2009-02-23 JP JP2010549086A patent/JP2011513350A/ja active Pending
- 2009-02-23 WO PCT/EP2009/052100 patent/WO2009109477A1/en active Application Filing
- 2009-02-23 KR KR1020107022134A patent/KR20100119825A/ko active IP Right Grant
- 2009-02-23 BR BRPI0909634A patent/BRPI0909634A2/pt not_active IP Right Cessation
- 2009-02-23 EP EP09717442A patent/EP2262789A1/en not_active Withdrawn
- 2009-02-23 MX MX2010009574A patent/MX2010009574A/es active IP Right Grant
- 2009-02-26 US US12/393,058 patent/US8183380B2/en not_active Expired - Fee Related
-
2010
- 2010-08-19 IL IL207698A patent/IL207698A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100119825A (ko) | 2010-11-10 |
| US8183380B2 (en) | 2012-05-22 |
| CA2716122A1 (en) | 2009-09-11 |
| WO2009109477A1 (en) | 2009-09-11 |
| US20090227570A1 (en) | 2009-09-10 |
| AU2009221375A1 (en) | 2009-09-11 |
| JP2011513350A (ja) | 2011-04-28 |
| CN101959876A (zh) | 2011-01-26 |
| EP2262789A1 (en) | 2010-12-22 |
| IL207698A0 (en) | 2010-12-30 |
| MX2010009574A (es) | 2010-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2370462T3 (da) | Glucagon-analoger | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| DK2342317T3 (da) | Hængende-dråbe-plade | |
| DE602009000234D1 (de) | msignals | |
| DK3444343T3 (da) | Polypeptider | |
| BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
| DE602008003972D1 (de) | Sitzrücklehnungsmechanismus | |
| DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
| DK2336132T3 (da) | Morpholinpurinderivat | |
| DK2342454T3 (da) | Vindkraftanlæg | |
| DK2335031T3 (da) | In-line-måler | |
| DK2379557T3 (da) | Aminopyrazol-forbindelse | |
| DE602008003970D1 (de) | Strahlstromkalibriersystem | |
| DK2271613T3 (da) | Hydroxymethylcyklohexylaminer | |
| BRPI0907522A2 (pt) | biarlamidas | |
| DE112009001946A5 (de) | Mobelauszugsführung | |
| DE602009000488D1 (de) | Obstvereinzelvorrichtung | |
| BRPI0907863A2 (pt) | pirrolopirimidinacarboxamidas | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| DE112009000183A5 (de) | Sicherheitsvorreiber | |
| BRPI0909637A2 (pt) | 2-aminoquinolinas | |
| DE602009000862D1 (de) | Gehwagenbremse | |
| AT507449A3 (de) | Dämmstoffbefestiger | |
| DE602009001190D1 (de) | Gleichstromumrichtervorrichtung | |
| ES1067763Y (es) | Dendrometro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |